BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22408025)

  • 1. Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.
    Liu Y; Korte FS; Moussavi-Harami F; Yu M; Razumova M; Regnier M; Chin MT
    Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1860-70. PubMed ID: 22408025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
    Liu Y; Yu M; Wu L; Chin MT
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.
    Hartman ME; Liu Y; Zhu WZ; Chien WM; Weldy CS; Fishman GI; Laflamme MA; Chin MT
    FASEB J; 2014 Jul; 28(7):3007-15. PubMed ID: 24687990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.
    Yu M; Liu Y; Xiang F; Li Y; Cullen D; Liao R; Beyer RP; Bammler TK; Chin MT
    OMICS; 2009 Dec; 13(6):501-11. PubMed ID: 20001863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
    Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.
    Koibuchi N; Chin MT
    Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility.
    Prestle J; Janssen PM; Janssen AP; Zeitz O; Lehnart SE; Bruce L; Smith GL; Hasenfuss G
    Circ Res; 2001 Feb; 88(2):188-94. PubMed ID: 11157671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.
    Zhang X; Tallini YN; Chen Z; Gan L; Wei B; Doran R; Miao L; Xin HB; Kotlikoff MI; Ji G
    Cardiovasc Res; 2009 Nov; 84(2):253-62. PubMed ID: 19578067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis.
    Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M
    Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
    Doi M; Yano M; Kobayashi S; Kohno M; Tokuhisa T; Okuda S; Suetsugu M; Hisamatsu Y; Ohkusa T; Kohno M; Matsuzaki M
    Circulation; 2002 Mar; 105(11):1374-9. PubMed ID: 11901051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.
    Xin HB; Senbonmatsu T; Cheng DS; Wang YX; Copello JA; Ji GJ; Collier ML; Deng KY; Jeyakumar LH; Magnuson MA; Inagami T; Kotlikoff MI; Fleischer S
    Nature; 2002 Mar; 416(6878):334-8. PubMed ID: 11907581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R; Yi QJ; Qian YR; Liu XY
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.
    Sakata Y; Koibuchi N; Xiang F; Youngblood JM; Kamei CN; Chin MT
    J Mol Cell Cardiol; 2006 Feb; 40(2):267-73. PubMed ID: 16242143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor CHF1/Hey2 regulates coronary vascular maturation.
    Watanabe T; Koibuchi N; Chin MT
    Mech Dev; 2010; 127(9-12):418-27. PubMed ID: 20619341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure.
    Yano M; Kobayashi S; Kohno M; Doi M; Tokuhisa T; Okuda S; Suetsugu M; Hisaoka T; Obayashi M; Ohkusa T; Kohno M; Matsuzaki M
    Circulation; 2003 Jan; 107(3):477-84. PubMed ID: 12551874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure.
    Yano M; Ono K; Ohkusa T; Suetsugu M; Kohno M; Hisaoka T; Kobayashi S; Hisamatsu Y; Yamamoto T; Kohno M; Noguchi N; Takasawa S; Okamoto H; Matsuzaki M
    Circulation; 2000 Oct; 102(17):2131-6. PubMed ID: 11044432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca
    Yang J; Zhang R; Jiang X; Lv J; Li Y; Ye H; Liu W; Wang G; Zhang C; Zheng N; Dong M; Wang Y; Chen P; Santosh K; Jiang Y; Liu J
    J Biol Chem; 2018 Jan; 293(3):794-807. PubMed ID: 29150444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction.
    Raake PW; Zhang X; Vinge LE; Brinks H; Gao E; Jaleel N; Li Y; Tang M; Most P; Dorn GW; Houser SR; Katus HA; Chen X; Koch WJ
    Circulation; 2012 May; 125(17):2108-18. PubMed ID: 22496128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.